Corteva, Inc. (NYSE:CTVA) Stake Increased by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lifted its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 97.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,961,440 shares of the company's stock after buying an additional 967,118 shares during the period. Price T Rowe Associates Inc. MD owned about 0.29% of Corteva worth $111,726,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of CTVA. World Investment Advisors LLC acquired a new position in shares of Corteva in the 3rd quarter valued at about $319,000. Wilmington Savings Fund Society FSB increased its stake in Corteva by 247.9% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 44,080 shares of the company's stock valued at $2,591,000 after buying an additional 31,411 shares during the period. Franklin Resources Inc. lifted its position in Corteva by 6.1% in the 3rd quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock worth $860,746,000 after buying an additional 856,007 shares in the last quarter. 1ST Source Bank boosted its stake in shares of Corteva by 1.9% during the 3rd quarter. 1ST Source Bank now owns 19,195 shares of the company's stock valued at $1,128,000 after buying an additional 367 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of Corteva by 6.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,605,608 shares of the company's stock valued at $270,764,000 after acquiring an additional 288,885 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.14% of the company's stock.

Corteva Stock Performance

CTVA opened at $61.50 on Monday. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock's 50 day moving average price is $60.71 and its two-hundred day moving average price is $60.44. The firm has a market capitalization of $42.01 billion, a P/E ratio of 47.67, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Citigroup lifted their price objective on Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. Bank of America boosted their price target on Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. Argus upgraded Corteva from a "hold" rating to a "buy" rating and set a $69.00 price objective on the stock in a report on Monday, March 31st. Royal Bank of Canada lifted their target price on shares of Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. Finally, Wells Fargo & Company increased their price target on shares of Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of "Moderate Buy" and a consensus price target of $68.13.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.